About the Industry Advisory Board
The COMBINEDBrain Industry Advisory Board is made up of representatives nominated by our Industry Members. Industry Membership is open to for-profit corporations who are developing treatments for rare genetic neurodevelopmental disorders, in any related aspect of health care, including diagnostics, therapeutics, medical devices, data management and contract research organizations.
The disorders represented by COMBINEDBrain are severe and devastating, with lifelong impacts on family caregivers as well as patients. The need and potential for treatment is great. We recognize that a true partnership between caregivers, researchers, clinicians and industry is the best and fastest way to bring successful treatments to patients. We need you, and we need each other.
Membership Benefits for Industry
Membership in COMBINEDBrain brings you to the table with leaders of our patient advocacy group members, as well as researchers and clinicians working to fast-track clinical trials for rare single-gene disorders of cognition. COMBINEDBrain members work together on fundamental pre-competitive projects which synergize pre-clinical drug development across our disorders.
- Invitations to participate in quarterly updates on COMBINEDBrain projects.
- Invitation to participate in an annual meeting on biomarkers and outcome measures for neurodevelopmental disorders (virtual in 2022)
- Special recognition on our website and promotional materials
- One seat on our Industry Advisory Board
- Sponsorship opportunities for specific projects
- Networking opportunities
Membership fees follow a sliding scale based on the annual budget of the entity as follows:
Annual Budget <$ 2,000,000 annual fees = $ 1,000
Annual Budget $ 2 – 5,000,000 annual fees = $ 5,000
Annual Budget $ 5-10,000,000 annual fees = $10,000
Annual Budget >$ 10,000,000 annual fees = $20,000